Barbara Ryan | Investor Relations |
Greg Williams | Chief Executive Officer |
Matthew Goddeeris | Vice President of Research |
Stephen MacDonald | Vice President of Finance and Accounting |
Ted Tenthoff | Piper Sandler |
Michelle Gilson | Canaccord |
Good afternoon everyone and welcome to the Eloxx Pharmaceuticals Fourth Quarter and Full Year 2020 earnings webcast and conference call. Today's call is being recorded. At this time, I would like to turn the call over to Barbara Ryan, Eloxx Investor Relations. Please begin.
Thank you, Victor.